{"id":130735,"title":"DSEN Abstract: How does real world use of insulin glargine compare to NPH insulin in terms of effectiveness and safety for the management of type 1 diabetes mellitus (T1DM)? - CIHR","sourceCode":"cihr","sourceName":"Canadian Institutes of Health Research","language":"en","captureDate":"2025-04-10","captureTimestamp":"2025-04-10T11:19:52.210000+00:00","jobId":2,"originalUrl":"https://cihr-irsc.gc.ca/e/51607.html?wbdisable=true","snippet":"DSEN Abstract: How does real world use of insulin glargine compare to NPH insulin in terms of effectiveness and safety for the management of type 1 diabetes mellitus (T1DM)? - CIHR Skip to main content Skip to \"About this site\" Canada.ca Services Departments Language selection…","rawSnapshotUrl":"/api/snapshots/raw/130735","browseUrl":"https://replay.healtharchive.ca/job-2/20250410111952/https://cihr-irsc.gc.ca/e/51607.html?wbdisable=true#ha_snapshot=130735","mimeType":"text/html","statusCode":200}